
    
      Antibiotic resistance is a severe threat to contemporary medicine. Effective approaches to
      fight multi-drug resistant pathogenic bacteria are needed.

      This clinical observational study is to investigate whether express extended spectrum beta
      lactamases (ESBL) E. coli colonizing the human gut can be out-competed by other, ideally
      pan-sensitive strains (non-ESBL E. coli).
    
  